A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult Participants
Status:
Completed
Trial end date:
2021-02-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of multiple doses of strong cytochrome
P450 (CYP) 3A4 inhibitor itraconazole and strong CYP3A4 inducer rifampin on the single dose
pharmacokinetics (PK) of lazertinib in healthy adult participants.